N¹,N²-bis(4-ethylbenzyl)ethane-1,2-diamine | 1043893-47-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: N¹,N²-bis(4-ethylbenzyl)ethane-1,2-diamine
• 英文别名: N,N'-bis(4-ethylbenzyl)ethane-1,2-diamine；N,N'-bis[(4-ethylphenyl)methyl]ethane-1,2-diamine
• CAS: 1043893-47-5
• 化学式: C₂₀H₂₈N₂
• 分子量: 296.456
• InChiKey: FKJLUBFUVIGVQS-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.9
• 重原子数：
  22
• 可旋转键数：
  9
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.4
• 拓扑面积：
  24.1
• 氢给体数：
  2
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  N¹,N²-bis(4-ethylbenzyl)ethane-1,2-diamine 在 lithium aluminium tetrahydride 、 三乙胺 作用下， 以 四氢呋喃 、 甲苯 为溶剂， 生成 (1,4-bis(4-ethylbenzyl)piperazin-2-yl)methanol
  参考文献：
  名称：

  Synthesis and biological evaluation of novel cYY analogues targeting Mycobacterium tuberculosis CYP121A1

  摘要：

  The rise in multidrug resistant (MDR) cases of tuberculosis (TB) has led to the need for the development of TB drugs with different mechanisms of action. The genome sequence of Mycobacterium tuberculosis (Mtb) revealed twenty different genes coding for cytochrome P450s. CYP121A1 catalyzes a C-C crosslinking reaction of di-cyclotyrosine (cYY) producing mycocyclosin and current research suggests that either mycocyclosin is essential or the overproduction of cYY is toxic to Mtb. A series of 1,4-dibenzyl-2-imidazol-1-yl-methylpiperazine derivatives were designed and synthesised as cYY mimics. The derivatives substituted in the 4-position of the phenyl rings with halides or alkyl group showed promising antimycobacterial activity (MIC 6.25 mu g/mL), with the more lipophilic branched alkyl derivatives displaying optimal binding affinity with CYP121A1 (Pr-i K-D = 1.6 mu M; Bu-t K-D = 1.2 mu M). Computational studies revealed two possible binding modes within the CYP121A1 active site both of which would effectively block cYY from binding.

  DOI：

  10.1016/j.bmc.2019.02.051
• 作为产物：
  描述：

  4-乙基苯甲醛 在 sodium tetrahydroborate 作用下， 以 甲醇 为溶剂， 生成 N¹,N²-bis(4-ethylbenzyl)ethane-1,2-diamine
  参考文献：
  名称：

  制备一系列带有N-杂环卡宾配体的Ru（ii）配合物，用于芳族酮的催化转移氢化†

  摘要：

  [RuCl 2（p- Cymene）2与Ag- N-杂环卡宾（NHC）配合物的反应产生了一系列[[ p- Cymene）Ru（NHC）]配合物（2a–f），所有合成的化合物均经过了表征通过元素分析，NMR光谱和X射线晶体学测定2a的分子结构，所有配合物均已作为芳香族酮转移加氢的催化剂进行了测试，显示出优异的活性。

  DOI：

  10.1039/c1dt11203a

文献信息

• Reversible Aminal Formation: Controlling the Evaporation of Bioactive Volatiles by Dynamic Combinatorial/Covalent Chemistry
  作者：Barbara Buchs née Levrand、Guillaume Godin、Alain Trachsel、Jean-Yves de Saint Laumer、Jean-Marie Lehn、Andreas Herrmann

  DOI：10.1002/ejoc.201001433

  日期：2011.2

  aqueous solutions. Kinetic rate constants and equilibrium constants for the formation and hydrolysis of aminals were determined. The performance of dynamic mixtures as delivery systems for perfumery ingredients was tested after deposition onto cotton, and the long-lastingness of fragrance evaporation was investigated by dynamic headspace analysis against a reference sample. The simplicity of the concept

  由可逆胺形成产生的动态混合物有效地延长了生物活性挥发性醛的蒸发持续时间。用于生成动态混合物的仲二胺是通过用羰基化合物处理伯二胺并用 NaBH 4 还原二亚胺来获得的。通过在缓冲水溶液中的核磁共振测量证明了反应的可逆性。测定了缩醛胺形成和水解的动力学速率常数和平衡常数。在沉积到棉花上后，测试了动态混合物作为香料成分传递系统的性能，并通过动态顶空分析针对参考样品研究了香味蒸发的持久性。概念的简单性及其出色的性能使该递送系统对应用香水非常感兴趣。可逆的氨基形成也可能成功地应用于动态组合/共价化学，以筛选药物或催化活性配体和受体。
• Preparation of a series of Ru(<scp>ii</scp>) complexes with N-heterocyclic carbeneligands for the catalytic transfer hydrogenation of aromatic ketones
  作者：Nevin Gürbüz、Emine Özge Özcan、İsmail Özdemir、Bekir Çetinkaya、Onur Şahin、Orhan Büyükgüngör

  DOI：10.1039/c1dt11203a

  日期：——

  [RuCl2(p-cymene]2 with Ag–N-heterocyclic carbene (NHC) complexes yields a series of [(p-cymene)Ru(NHC)] complexes (2a–f). All synthesised compounds were characterized by elemental analysis, NMR spectroscopy and the molecular structure of 2a was determined by X-ray crystallography. All complexes have been tested as catalysts for the transfer hydrogenation of aromatic ketones, showing excellent activity in this reaction

  [RuCl 2（p- Cymene）2与Ag- N-杂环卡宾（NHC）配合物的反应产生了一系列[[ p- Cymene）Ru（NHC）]配合物（2a–f），所有合成的化合物均经过了表征通过元素分析，NMR光谱和X射线晶体学测定2a的分子结构，所有配合物均已作为芳香族酮转移加氢的催化剂进行了测试，显示出优异的活性。
• CONTROLLED RELEASE OF ACTIVE ALDEHYDES AND KETONES FROM EQUILIBRATED DYNAMIC MIXTURES
  申请人：Herrmann Andreas

  公开号：US20100098650A1

  公开（公告）日：2010-04-22

  The present invention concerns a dynamic mixture obtained by combining, in the presence of water, at least one diamine derivative that includes at least one benzylamine moiety, with at least one active aldehyde or ketone. The inventive mixture is capable of releasing in a controlled and prolonged manner the active compound, in particular those that are perfuming ingredients, into the surrounding environment.

  本发明涉及一种动态混合物，其是通过在水存在下，将至少含有至少一个苄胺基团的二胺衍生物与至少一种活性醛或酮相结合而获得的。本发明的混合物可以控制并延长地释放活性化合物，特别是香料成分，进入周围环境。
• [EN] CONTROLLED RELEASE OF ACTIVE ALDEHYDES AND KETONES FROM EQUILIBRATED DYNAMIC MIXTURES<br/>[FR] LIBÉRATION CONTRÔLÉE D'ALDÉHYDES ET DE CÉTONES ACTIFS DE MÉLANGES DYNAMIQUES ÉQUILIBRÉS
  申请人：FIRMENICH & CIE

  公开号：WO2008093272A2

  公开（公告）日：2008-08-07

  [EN] The present invention concerns a dynamic mixture obtained by combining, in the presence of water, at least one diamine derivative, comprising at least one benzylamine moiety, with at least one active aldehyde or ketone. The invention's mixture is capable of releasing in a controlled and prolonged manner said active compound, in particular perfuming ingredients, in the surrounding environment.
  [FR] La présente invention concerne un mélange dynamique obtenu par combinaison, en présence d'eau, d'au moins un dérivé diamine, comprenant au moins une fraction benzylamine, avec au moins un aldéhyde ou une cétone actifs. Le mélange de l'invention est capable de libérer de manière contrôlée et prolongée ledit composé actif, en particulier des ingrédients parfumants, dans l'environnement.
• Synthesis and biological evaluation of novel cYY analogues targeting Mycobacterium tuberculosis CYP121A1
  作者：Safaa M. Kishk、Kirsty J. McLean、Sakshi Sood、Mohamed A. Helal、Mohamed S. Gomaa、Ismail Salama、Samia M. Mostafa、Luiz Pedro S. de Carvalho、Andrew W. Munro、Claire Simons

  DOI：10.1016/j.bmc.2019.02.051

  日期：2019.4

  The rise in multidrug resistant (MDR) cases of tuberculosis (TB) has led to the need for the development of TB drugs with different mechanisms of action. The genome sequence of Mycobacterium tuberculosis (Mtb) revealed twenty different genes coding for cytochrome P450s. CYP121A1 catalyzes a C-C crosslinking reaction of di-cyclotyrosine (cYY) producing mycocyclosin and current research suggests that either mycocyclosin is essential or the overproduction of cYY is toxic to Mtb. A series of 1,4-dibenzyl-2-imidazol-1-yl-methylpiperazine derivatives were designed and synthesised as cYY mimics. The derivatives substituted in the 4-position of the phenyl rings with halides or alkyl group showed promising antimycobacterial activity (MIC 6.25 mu g/mL), with the more lipophilic branched alkyl derivatives displaying optimal binding affinity with CYP121A1 (Pr-i K-D = 1.6 mu M; Bu-t K-D = 1.2 mu M). Computational studies revealed two possible binding modes within the CYP121A1 active site both of which would effectively block cYY from binding.